☰

David D. Vail - Publications

Affiliations: 
University of Nebraska at Kearney, Kearney, NE, United States 
 2012 History Kansas State University, Manhattan, KS, United States 
Area:
Environmental and Agricultural History, History of Science, Technology, and Medicine, and Public History
Website:
https://www.unk.edu/academics/history/david-vail.php
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Moirano S, Turek M, Sanchez D, Vail D, Van Asselt N, Lawrence J, Forrest L. Intensity-modulated radiotherapy and chemotherapy for canine right atrial tumors: A retrospective study of seven dogs. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. PMID 37800663 DOI: 10.1111/vru.13303  0.732
2021 Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, et al. Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science Translational Medicine. 13. PMID 34261797 DOI: 10.1126/scitranslmed.abb3631  0.729
2020 Stevens A, Turek M, Vail D, Christensen N, Forrest L. Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017). Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. PMID 32713101 DOI: 10.1111/vru.12899  0.737
2016 Saba C, Paoloni M, Mazcko C, Kisseberth W, Burton JH, Smith A, Wilson-Robles H, Allstadt S, Vail D, Henry C, Lana S, Ehrhart EJ, Charles B, Kent M, Lawrence J, et al. A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model. Plos One. 11: e0149194. PMID 26866698 DOI: 10.1371/journal.pone.0149194  0.754
2015 Khanna C, Vail D, Rosenberg M. Letter to Editor. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. PMID 26617055 DOI: 10.1111/jvim.13790  0.674
2015 Paoloni M, Mazcko C, Selting K, Lana S, Barber L, Phillips J, Skorupski K, Vail D, Wilson H, Biller B, Avery A, Kiupel M, LeBlanc A, Bernhardt A, Brunkhorst B, et al. Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma. Plos One. 10: e0129954. PMID 26091536 DOI: 10.1371/journal.pone.0129954  0.715
2014 Paoloni M, Webb C, Mazcko C, Cherba D, Hendricks W, Lana S, Ehrhart EJ, Charles B, Fehling H, Kumar L, Vail D, Henson M, Childress M, Kitchell B, Kingsley C, et al. Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. Plos One. 9: e90028. PMID 24637659 DOI: 10.1371/Journal.Pone.0090028  0.761
2012 Vail DD. Toxic fables: the advertising and marketing of agricultural chemicals in the great plains, 1945-1985. Endeavour. 36: 165-73. PMID 23177323 DOI: 10.1016/J.Endeavour.2012.09.007  0.695
2009 Khanna C, London C, Vail D, Mazcko C, Hirschfeld S. Guiding the optimal translation of new cancer treatments from canine to human cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5671-7. PMID 19737961 DOI: 10.1158/1078-0432.CCR-09-0719  0.737
2009 Vail D, Hellmén E. International Veterinary Cancer Meetings 2003. Veterinary and Comparative Oncology. 1: 169-70. PMID 19379177 DOI: 10.1111/j.1476-5810.2003.00034.x  0.741
2009 Paoloni MC, Tandle A, Mazcko C, Hanna E, Kachala S, Leblanc A, Newman S, Vail D, Henry C, Thamm D, Sorenmo K, Hajitou A, Pasqualini R, Arap W, Khanna C, et al. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature. Plos One. 4: e4972. PMID 19330034 DOI: 10.1371/Journal.Pone.0004972  0.749
2008 Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne IN, Wolfgang GH, Desai M, Rhodes GR, ... ... Vail D, et al. GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2824-32. PMID 18451250 DOI: 10.1158/1078-0432.Ccr-07-2061  0.708
2008 Lawrence J, Forrest L, Adams W, Vail D, Thamm D. Four-fraction radiation therapy for macroscopic soft tissue sarcomas in 16 dogs. Journal of the American Animal Hospital Association. 44: 100-8. PMID 18451067 DOI: 10.5326/0440100  0.709
2006 Rusk A, Cozzi E, Stebbins M, Vail D, Graham J, Valli V, Henkin J, Sharpee R, Khanna C. Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7456-64. PMID 17189419 DOI: 10.1158/1078-0432.CCR-06-0110  0.746
2006 Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, Barber L, Breen M, Kitchell B, McNeil E, Modiano JF, Niemi S, Comstock KE, Ostrander E, Westmoreland S, Withrow S. The dog as a cancer model. Nature Biotechnology. 24: 1065-6. PMID 16964204 DOI: 10.1038/Nbt0906-1065B  0.746
Show low-probability matches.